leisure time -WSS

leisure time

author：Wikipedia 2025-09-06 05:26:42 - browse：1142

An experimental drug from Insmed Incorporated successfully reduced lung problems among patients with an airway disease in a closely watched Phase 3 trial, sending the company’s share price soaring early Tuesday.

The drug, brensocatib, reduced so-called pulmonary exacerbations by roughly 20% versus placebo in patients with bronchiectasis, hitting the trial’s primary endpoint. The trial, called the ASPEN study, tested two dosages of the drug, and the company said both significantly cut rates of pulmonary exacerbations.

Insmed shares more than doubled in pre-market trading. Analysts have forecasted that brensocatib could lead to billions of dollars in annual sales if approved.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Community addresses injustice for Long Island mothers

explore

WSS

Listen: Biogen's messy board & Laronde's data problem

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Bacterial infection may be ‘key event’ in endometriosis, study says

Cuban government calls US nuclear submarine stop a 'provocative escalation'

The debate over Covid

Inflation cooled significantly in June, bringing price hikes close to normal levels

Wikipedia

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Psychedelics group wrestles with new pharma identity

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

After affirmative action ruling, medical educators look to 'holistic review'

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Psychedelics group wrestles with new pharma identity

Why is France rioting? What to know about the fatal police shooting of Nahel M

Virginia high school admissions case could be legal follow

PhRMA sues HHS over Medicare drug price negotiation

Psychedelics group wrestles with new pharma identity

Make 'food is medicine' a key part of White House nutrition meeting

focus

4th of July breaks record for highest global temperature ever measured

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Women's World Cup brings attention to abuse in soccer

Grail is spending more than ever lobbying Congress

Grail's uphill battle for Medicare to cover its cancer screening test

explore

Wikipedia

explore

knowledge